13:00 - 14:35
Monday 2nd November 2020

Book your place

This webinar is managed by Medicines Discovery Catapult.
We take your data protection seriously. For more information, read our Privacy Policy

13:00 Welcome and introduction
Dr Sarah Wagstaffe, Head of Translational Research Office, University of Oxford

13:05 Introduction to MDC
Professor Chris Molloy, CEO, MDC

13:20 Together, we will catapult the discovery of new medicines
Professor Chas Bountra, Professor of Translational Medicine, University of Oxford   

13:35 Virtual R&D at MDC
Dr Graeme Wilkinson, Head of Virtual R&D, MDC

13:50 Informatics at MDC
Dr Mark Davies, Business Development Manager for Informatics, MDC

14:05 How to build a robust translational strategy - panel discussion and audience Q&A
Chaired by Dr Sarah Wagstaffe, Head of Translational Research Office, University of Oxford


14:30 Close and next steps

Dr Sarah Wagstaffe, Head of Translational Research Office, University of Oxford

Agenda

Accelerating the translation and commercialisation of your medicines discovery

The Translation Research Office at the University of Oxford is hosting Professor Chris Molloy, CEO of MDC, and Professor Chas Bountra, Pro Vice-Chancellor for Innovation, to discuss how engagement with MDC can speed up translational and commercial success.

We will discuss how the organisations are working together, how MDC's virtual R&D team can plan your most efficient route to clinic, and how informatics can help to create better lead molecules.

The session will incorporate a Q&A on translational strategy and we would strongly recommend you book a virtual 1:1 with the team to discuss your research. MDC and the Translational Research Office are keen to hear about your work, no matter how early in development it is.

If you wish to give a summary before please do, but it's not required, we're happy to explore with you!

We hope you will be able to join us.

Collaboration opportunities with Medicines Discovery Catapult (MDC)